STEPHANIE ONYEFORO: Open Payments
NPI 1942816665 · BARRINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,258 in 110 payments from 15 companies in 2025. Trend: 2023 $717 · 2024 $801 · 2025 $2,258
Food & beverage: $2,146Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 36 | $548 |
| Neurocrine BioSciences, Inc. | 17 | $391 |
| Teva Pharmaceuticals USA, Inc. | 15 | $378 |
| ABBVIE INC. | 9 | $215 |
| Lundbeck LLC | 7 | $161 |
| Alkermes, Inc. | 5 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Janssen Pharmaceuticals, Inc | 4 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
Products named: ABILIFY ASIMTUFII, INGREZZA, REXULTI, VRAYLAR, AUSTEDO XR, LYBALVI, TRINTELLIX, UZEDY.
Industry payments across IL — which companies pay providers there.
